EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer

Mariana Pereira iD, Nuno Vale iD

Genes · 2026

DOI: 10.3390/genes17020184 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2026. Verfasst von Mariana Pereira und 1 weiteren Autor:innen. Beteiligte Einrichtung: PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Drug Repositioning, Urinary Bladder Neoplasms, Anti-Retroviral Agents. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gene expression-guided drug repurposing has emerged as a strategy to identify new therapy opportunities by associating disease transcriptional signatures with drug-induced gene expression profiles. This is relevant for prostate and bladder cancers, which have high molecular heterogeneity and therapy resistance limits for their standard treatment regimens. Antiretrovirals have been of great interest as repurposed candidates for these cancers due to their various effects on cancer cell pathways. The objective of this review is to assess the principles, applications, and challenges of this approach, with emphasis on antiretrovirals.

Methods

This review summarizes published literature on gene expression-based drug repurposing methodologies, including signature reversion, pathway level analysis, and validation studies. Studies applying these concepts to prostate and bladder cancer were analyzed, and evidence of antiretroviral repurposing for cancer therapy was assessed based on transcriptomic alterations, pathway perturbation, and preclinical outcomes.

Results

Transcriptomic-driven studies identified several drug candidates capable of modulating gene expression associated with therapy resistance, tumor progression, and cell stress responses. The anticancer effects of antiretrovirals were shown to be related to cell cycle arrest, apoptosis, metabolic alterations, and proteostasis. Nonetheless, transcriptomic responses are highly context-dependent and can be influenced by tumor subtype and experiment and treatment conditions. Off-target effects can also complicate mechanism interpretation.

Conclusions

Gene expression–guided drug repurposing enables the systematic prioritization of clinically actionable candidates by matching disease and drug transcriptional signatures, but successful translation will require the integration of other omics results, careful model selection, and the development of clinically relevant biomarkers to support mechanism-informed repurposing. Translation will depend on subtype-aware signature matching, integration with complementary omics, and biomarker-backed validation to support precision deployment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDrug RepositioningUrinary Bladder NeoplasmsAnti-Retroviral AgentsHumansMaleGene Expression Regulation, NeoplasticTranscriptomeGene Expression ProfilingAntineoplastic Agents

Stichwörter der Autor:innen

Connectivity MapLINCS L1000antiretroviral repurposingbiomarker stratificationbladder cancerfunctional genomicsprecision oncologyprostate cancertranscriptomic signatures

Substanzen

Anti-Retroviral AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
  • ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
  • RISE-Health, Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal.
  • Laboratory of Personalized Medicine, Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal.

ORCID-Profile: Mariana Pereira, Nuno Vale

Zitieren

APA

Pereira, M., & Vale, N. (2026). Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer. Genes. https://doi.org/10.3390/genes17020184

Vancouver

Pereira M, Vale N. Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer. Genes. 2026. doi:10.3390/genes17020184

BibTeX
@article{Pereira2026,
  author = {Pereira, Mariana and Vale, Nuno},
  title = {Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17020184}
}
Kostenlos starten →